| CTRI Number |
CTRI/2018/06/014373 [Registered on: 01/06/2018] Trial Registered Prospectively |
| Last Modified On: |
30/05/2018 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Siddha |
| Study Design |
Other |
|
Public Title of Study
|
To evaluate the clinical efficacy of Keel Vayu Nivarana Chooranam(Internal), Vathathirku Thylam(External) for the treatment of Uthiravatha Suronitham(Rheumatoid Arthritis) |
|
Scientific Title of Study
|
An Open Clinical Study to evaluate the efficacy of Siddha polyherbal medicine Keelvayu Nivarana Chooranam(Internal), Vathathirku Thylam(External) and Vedhu(External Therapy) for the treatment of Uthiravatha Suronitham(Rheumatoid Arthritis) |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
BDurga Devi |
| Designation |
PG Scholar |
| Affiliation |
Govt Siddha Medical College Hospital |
| Address |
Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital
Tirunelveli
Tirunelveli TAMIL NADU 627002 India |
| Phone |
|
| Fax |
|
| Email |
dr.devidurga29@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Poongodigandhimathi |
| Designation |
Professor |
| Affiliation |
Govt Siddha Medical College Hospital |
| Address |
Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital
Tirunelveli
Tirunelveli TAMIL NADU 627002 India |
| Phone |
|
| Fax |
|
| Email |
arunapriya1995@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
BDurga Devi |
| Designation |
PG Scholar |
| Affiliation |
Govt Siddha Medical College Hospital |
| Address |
Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital
Tirunelveli
Tirunelveli TAMIL NADU 627002 India |
| Phone |
|
| Fax |
|
| Email |
dr.devidurga29@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
BDurga Devi |
| Address |
Op No-4, Department of Sirappu Maruthuvam,
Govt Siddha Medical College Hospital Tirunelveli |
| Type of Sponsor |
Other [PG Scholar Stipend] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| BDurga Devi |
Govt Siddha Medical College Hospital Tirunelveli |
Op No-4, Department of Sirappu Maruthuvam, Govt Siddha Medical College Hospital,
Tirunelveli Tirunelveli TAMIL NADU |
2572736
dr.devidurga29@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC Govt Siddha Medical College Palayamkottai |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
Patients suffering from Rheumatoid arthritis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Keelvayu Nivarana Chooranam and Vathathirku Thylam |
Keelvayu Nivarana Chooranam-650-1300mg-oral route twice daily and Vathathirku thylam-30ml(External) |
| Comparator Agent |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1. Symmetrical joint involvement
2. Arthritis of 3 or more joints
3. Rheumatoid factor positive
4. Morning stiffness
5. Swelling especially in the inter phalangeal joint.
6. Patients who are willing for admission and stay in IPD for 30 to 48 days or willing to attend OPD
7. Patient who is willing to undergo radiological investigation and give blood and urine samples for laboratory investigation.
8. Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment during 30 to 48 days but can OPD out of the trial of his/her own conscious discretion.
|
|
| ExclusionCriteria |
| Details |
1. Systemic illness.
2. Pregnant Women and Lactating Mother
3. History of trauma
4. Neurological disorder
5. Tubercular arthritis
6. Any other serious illness
7. Psoriatic arthritis
8. Gouty arthritis
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the clinical efficacy of “KEELVAYU NIVARANA CHOORANAM †(internal) & “VATHATHIRKU THYLAM†(external) and External Therapy Vedhu in reducing the pain and restricted joint movements in the treatment of ‘Uthiravatha suronitham†(rheumatoid arthritis). |
48 Days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To study the effect of Vedhu (steam bath) in reducing the pain towards the efficacy of medicine. |
48 Days |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
02/07/2018 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
None Yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Study enrollment:
Patients
reporting at the OPD of Govt. Siddha medical college and hospital, Palayamkottai.
With the clinical symptoms the
Symmetrical joint involvement, Arthrits of 3 or more joints, morning
stiffness Swelling especially in the
inter phalangeal joints, will be examined clinically for enrolling in the study
based on the inclusion and exclusion criteria.
The patients who are to be enrolled
would be informed (form iv) about the study, trial drug, possible outcomes and
the objectives of the study in the language and terms understandable to them.
After ascertaining the patient’s
willingness, informed consent would be obtained in writing from them in the
consent form (form iv). All these
patients will be given unique registration card in which patient’s registration
number of the study, address, phone number and doctor’s phone number etc., will
be given, so as to report easily should any complications arise.
complete clinical history,
complaints and duration, examination findings—all would be recorded in the
prescribed proforma in the history and clinical assessment forms separately. Screening form – i will be filled up. Form – ii and form – iii will be used for
recording the patient’s history, clinical examination of symptoms and signs and
laboratory investigations respectively.
Patients would be advised to take the trial drug and appropriate dietary
advice (form iv-d) would be given according to the patient’s perfect
understanding. Conduct of the study:
15ml of Vellai ennai is given in
early morning, on the very first day of treatment for purgation. This will help
to bring the vitiated mukkutram back to normal. From the next day, the trial
drug is given for treatment.
Then
the trial drug KEELVAYU NIVARANA
CHOORANAM (internal), VATHATHIRKU THYLAM (external) is given
continuously for 30 to 48 days. OP patients should visit the hospital once in seven
days. At each clinical visit clinical
assessment is done and prognosis is noted.
For IP patients the drug is given for 40 days and the clinical
assessment is done daily. patients will be given Vedhu (steam bath) treatment
along with their internal medicine. The results will be compared at the end of
the study. Laboratory investigations & radiological investigation are done
0 day, 20th day, 40th day of the trial. For IP patients,
who are not in a situation to stay in the hospital for a long time is advised
to attend the OPD for further follow-up. After the end of the treatment, the
patient is advised to visit the OPD for another 2 months for follow-up. If any
trial patient who fails to collect the trial drug on the prescribed day but
wants to continue in the trial from the next day , he/she will be allowed, but
defaulters of one week and more will not be allowed to continue and be withdrawn
from the study with a fresh case being included.
Data management:
After enrolling the patient for the
study, a separate file for each patient will be opened and all forms will be
kept in the file. Study No. and patient
identity No. will be written on the top of file for easy identification. Whenever study patient visits OPD during the
study period, the respective patient file will be taken and necessary entries
will be made at the assessment form or other suitable form. The screening forms will be filed separately. The data recordings will be monitored by HOD
and pharmaco-vigilance committee. All
forms will be further scrutinized in presence of investigators with concerned
department faculties for logical errors and incompleteness of data to avoid any
bias. No modification in the results is
permitted for unbiased report.
|